Clinical Trial Update: A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination [Phase 4]

View source ↗

Summary

Completed Phase 4 randomized trial evaluating two doses of GW433908 boosted with ritonavir in combination with abacavir/lamivudine, assessing efficacy, safety a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• GW433908
• Ritonavir (Ritonavir)

Snippet

Sponsor: Duke University | Conditions: HIV | Phase 4 | Status: COMPLETED